nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC1—Vandetanib—thyroid cancer	0.0767	0.104	CbGbCtD
Verapamil—ABCC10—Doxorubicin—thyroid cancer	0.0727	0.0985	CbGbCtD
Verapamil—ABCC4—Sorafenib—thyroid cancer	0.0575	0.078	CbGbCtD
Verapamil—ABCC1—Epirubicin—thyroid cancer	0.0528	0.0715	CbGbCtD
Verapamil—ABCG2—Vandetanib—thyroid cancer	0.0513	0.0696	CbGbCtD
Verapamil—ABCC3—Doxorubicin—thyroid cancer	0.0457	0.0619	CbGbCtD
Verapamil—ABCB11—Doxorubicin—thyroid cancer	0.0395	0.0535	CbGbCtD
Verapamil—ABCC2—Sorafenib—thyroid cancer	0.0342	0.0464	CbGbCtD
Verapamil—ABCG2—Sorafenib—thyroid cancer	0.0309	0.0419	CbGbCtD
Verapamil—ABCC1—Doxorubicin—thyroid cancer	0.0281	0.038	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0229	0.031	CbGbCtD
Verapamil—CYP3A7—Sorafenib—thyroid cancer	0.0229	0.031	CbGbCtD
Verapamil—CYP2B6—Sorafenib—thyroid cancer	0.0218	0.0295	CbGbCtD
Verapamil—ABCC2—Doxorubicin—thyroid cancer	0.0208	0.0281	CbGbCtD
Verapamil—ABCG2—Doxorubicin—thyroid cancer	0.0188	0.0254	CbGbCtD
Verapamil—CYP3A5—Sorafenib—thyroid cancer	0.0171	0.0232	CbGbCtD
Verapamil—CYP2C8—Sorafenib—thyroid cancer	0.0165	0.0223	CbGbCtD
Verapamil—CYP2C19—Sorafenib—thyroid cancer	0.0138	0.0187	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—thyroid cancer	0.0132	0.0179	CbGbCtD
Verapamil—CYP1A2—Sorafenib—thyroid cancer	0.0128	0.0173	CbGbCtD
Verapamil—CYP2C9—Sorafenib—thyroid cancer	0.0115	0.0156	CbGbCtD
Verapamil—ABCB1—Sorafenib—thyroid cancer	0.0112	0.0151	CbGbCtD
Verapamil—CYP3A4—Vandetanib—thyroid cancer	0.0111	0.015	CbGbCtD
Verapamil—CYP2D6—Sorafenib—thyroid cancer	0.0105	0.0142	CbGbCtD
Verapamil—ABCB1—Doxorubicin—thyroid cancer	0.00677	0.00917	CbGbCtD
Verapamil—CYP3A4—Sorafenib—thyroid cancer	0.00669	0.00906	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—thyroid cancer	0.00638	0.00864	CbGbCtD
Verapamil—SLC22A4—larynx—thyroid cancer	0.00567	0.0899	CbGeAlD
Verapamil—Hyperkeratosis—Sorafenib—thyroid cancer	0.00439	0.0463	CcSEcCtD
Verapamil—CYP3A4—Doxorubicin—thyroid cancer	0.00406	0.0055	CbGbCtD
Verapamil—CACNA1F—head—thyroid cancer	0.00273	0.0433	CbGeAlD
Verapamil—Ileus—Vandetanib—thyroid cancer	0.00263	0.0277	CcSEcCtD
Verapamil—CACNB4—thyroid gland—thyroid cancer	0.00202	0.0321	CbGeAlD
Verapamil—CACNB3—trachea—thyroid cancer	0.00196	0.0311	CbGeAlD
Verapamil—Respiratory failure—Vandetanib—thyroid cancer	0.0019	0.02	CcSEcCtD
Verapamil—CACNB4—head—thyroid cancer	0.0018	0.0285	CbGeAlD
Verapamil—CACNA1S—thyroid gland—thyroid cancer	0.00173	0.0275	CbGeAlD
Verapamil—CACNA1A—head—thyroid cancer	0.00171	0.0272	CbGeAlD
Verapamil—CACNA1B—head—thyroid cancer	0.00167	0.0266	CbGeAlD
Verapamil—CACNB1—thyroid gland—thyroid cancer	0.00162	0.0257	CbGeAlD
Verapamil—CACNB3—thyroid gland—thyroid cancer	0.00155	0.0246	CbGeAlD
Verapamil—CACNA1I—lymph node—thyroid cancer	0.00153	0.0243	CbGeAlD
Verapamil—SLC22A4—neck—thyroid cancer	0.0015	0.0238	CbGeAlD
Verapamil—CACNA1G—head—thyroid cancer	0.0015	0.0237	CbGeAlD
Verapamil—CACNB1—head—thyroid cancer	0.00143	0.0228	CbGeAlD
Verapamil—Cardiac failure—Vandetanib—thyroid cancer	0.00138	0.0146	CcSEcCtD
Verapamil—Lethargy—Vandetanib—thyroid cancer	0.00138	0.0145	CcSEcCtD
Verapamil—CACNB3—head—thyroid cancer	0.00138	0.0218	CbGeAlD
Verapamil—Cardiac arrest—Vandetanib—thyroid cancer	0.00128	0.0136	CcSEcCtD
Verapamil—ABCC10—saliva-secreting gland—thyroid cancer	0.00125	0.0198	CbGeAlD
Verapamil—CACNA1B—lymph node—thyroid cancer	0.00117	0.0186	CbGeAlD
Verapamil—Influenza—Vandetanib—thyroid cancer	0.00117	0.0123	CcSEcCtD
Verapamil—Bronchospasm—Vandetanib—thyroid cancer	0.00115	0.0121	CcSEcCtD
Verapamil—Gynaecomastia—Sorafenib—thyroid cancer	0.00112	0.0118	CcSEcCtD
Verapamil—CACNA1H—thyroid gland—thyroid cancer	0.0011	0.0175	CbGeAlD
Verapamil—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00109	0.0114	CcSEcCtD
Verapamil—Pollakiuria—Vandetanib—thyroid cancer	0.00108	0.0114	CcSEcCtD
Verapamil—CACNB2—thyroid gland—thyroid cancer	0.00104	0.0165	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00103	0.0109	CcSEcCtD
Verapamil—CACNB1—lymph node—thyroid cancer	0.001	0.0159	CbGeAlD
Verapamil—KCNJ11—thyroid gland—thyroid cancer	0.000989	0.0157	CbGeAlD
Verapamil—Sinusitis—Vandetanib—thyroid cancer	0.000977	0.0103	CcSEcCtD
Verapamil—CACNB3—lymph node—thyroid cancer	0.000963	0.0153	CbGeAlD
Verapamil—ABCC10—trachea—thyroid cancer	0.000962	0.0153	CbGeAlD
Verapamil—Bradycardia—Vandetanib—thyroid cancer	0.000951	0.01	CcSEcCtD
Verapamil—Cardiac failure—Sorafenib—thyroid cancer	0.000934	0.00985	CcSEcCtD
Verapamil—CACNB2—head—thyroid cancer	0.000924	0.0147	CbGeAlD
Verapamil—CACNA1D—thyroid gland—thyroid cancer	0.000911	0.0144	CbGeAlD
Verapamil—SLC22A4—trachea—thyroid cancer	0.000904	0.0143	CbGeAlD
Verapamil—Visual impairment—Vandetanib—thyroid cancer	0.000901	0.0095	CcSEcCtD
Verapamil—Erythema multiforme—Vandetanib—thyroid cancer	0.000884	0.00932	CcSEcCtD
Verapamil—KCNJ11—head—thyroid cancer	0.000877	0.0139	CbGeAlD
Verapamil—Alopecia—Vandetanib—thyroid cancer	0.000826	0.00871	CcSEcCtD
Verapamil—CACNA1D—head—thyroid cancer	0.000808	0.0128	CbGeAlD
Verapamil—Muscle spasms—Vandetanib—thyroid cancer	0.000782	0.00825	CcSEcCtD
Verapamil—SLC22A5—saliva-secreting gland—thyroid cancer	0.000776	0.0123	CbGeAlD
Verapamil—Vision blurred—Vandetanib—thyroid cancer	0.000767	0.00809	CcSEcCtD
Verapamil—ABCC3—thyroid gland—thyroid cancer	0.000765	0.0121	CbGeAlD
Verapamil—Tremor—Vandetanib—thyroid cancer	0.000762	0.00804	CcSEcCtD
Verapamil—ABCC10—thyroid gland—thyroid cancer	0.000761	0.0121	CbGeAlD
Verapamil—Abdominal discomfort—Sorafenib—thyroid cancer	0.000755	0.00797	CcSEcCtD
Verapamil—CACNA1C—head—thyroid cancer	0.000746	0.0118	CbGeAlD
Verapamil—ABCG2—saliva-secreting gland—thyroid cancer	0.00073	0.0116	CbGeAlD
Verapamil—Erectile dysfunction—Sorafenib—thyroid cancer	0.000725	0.00765	CcSEcCtD
Verapamil—SCN5A—head—thyroid cancer	0.000723	0.0115	CbGeAlD
Verapamil—SLC22A4—thyroid gland—thyroid cancer	0.000715	0.0113	CbGeAlD
Verapamil—Loss of consciousness—Vandetanib—thyroid cancer	0.000715	0.00754	CcSEcCtD
Verapamil—Convulsion—Vandetanib—thyroid cancer	0.000705	0.00744	CcSEcCtD
Verapamil—Hypertension—Vandetanib—thyroid cancer	0.000702	0.00741	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.000696	0.00734	CcSEcCtD
Verapamil—Chest pain—Vandetanib—thyroid cancer	0.000693	0.00731	CcSEcCtD
Verapamil—Arthralgia—Vandetanib—thyroid cancer	0.000693	0.00731	CcSEcCtD
Verapamil—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000692	0.0073	CcSEcCtD
Verapamil—Myocardial infarction—Sorafenib—thyroid cancer	0.000688	0.00726	CcSEcCtD
Verapamil—CACNA1H—lymph node—thyroid cancer	0.000685	0.0109	CbGeAlD
Verapamil—Jaundice—Sorafenib—thyroid cancer	0.000685	0.00722	CcSEcCtD
Verapamil—ABCC1—trachea—thyroid cancer	0.00068	0.0108	CbGeAlD
Verapamil—ABCC3—head—thyroid cancer	0.000678	0.0108	CbGeAlD
Verapamil—Dry mouth—Vandetanib—thyroid cancer	0.000677	0.00715	CcSEcCtD
Verapamil—Paralysis—Epirubicin—thyroid cancer	0.000668	0.00704	CcSEcCtD
Verapamil—Oedema—Vandetanib—thyroid cancer	0.000664	0.007	CcSEcCtD
Verapamil—Infection—Vandetanib—thyroid cancer	0.00066	0.00696	CcSEcCtD
Verapamil—Ileus—Epirubicin—thyroid cancer	0.000656	0.00691	CcSEcCtD
Verapamil—Nystagmus—Epirubicin—thyroid cancer	0.00065	0.00685	CcSEcCtD
Verapamil—CACNB2—lymph node—thyroid cancer	0.000647	0.0103	CbGeAlD
Verapamil—ABCC4—thyroid gland—thyroid cancer	0.000631	0.01	CbGeAlD
Verapamil—Paralysis—Doxorubicin—thyroid cancer	0.000618	0.00652	CcSEcCtD
Verapamil—KCNJ11—lymph node—thyroid cancer	0.000614	0.00974	CbGeAlD
Verapamil—Ileus—Doxorubicin—thyroid cancer	0.000607	0.0064	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000605	0.00638	CcSEcCtD
Verapamil—SLC22A1—head—thyroid cancer	0.000604	0.00959	CbGeAlD
Verapamil—Nystagmus—Doxorubicin—thyroid cancer	0.000601	0.00634	CcSEcCtD
Verapamil—Insomnia—Vandetanib—thyroid cancer	0.000601	0.00633	CcSEcCtD
Verapamil—SLC22A5—trachea—thyroid cancer	0.000598	0.00949	CbGeAlD
Verapamil—Paraesthesia—Vandetanib—thyroid cancer	0.000596	0.00629	CcSEcCtD
Verapamil—Erythema multiforme—Sorafenib—thyroid cancer	0.000596	0.00629	CcSEcCtD
Verapamil—Dyspnoea—Vandetanib—thyroid cancer	0.000592	0.00624	CcSEcCtD
Verapamil—Tinnitus—Sorafenib—thyroid cancer	0.000588	0.0062	CcSEcCtD
Verapamil—Flushing—Sorafenib—thyroid cancer	0.000585	0.00617	CcSEcCtD
Verapamil—Dyspepsia—Vandetanib—thyroid cancer	0.000584	0.00617	CcSEcCtD
Verapamil—SLCO1A2—head—thyroid cancer	0.000582	0.00923	CbGeAlD
Verapamil—Fatigue—Vandetanib—thyroid cancer	0.000572	0.00604	CcSEcCtD
Verapamil—Constipation—Vandetanib—thyroid cancer	0.000568	0.00599	CcSEcCtD
Verapamil—Pain—Vandetanib—thyroid cancer	0.000568	0.00599	CcSEcCtD
Verapamil—CACNA1D—lymph node—thyroid cancer	0.000566	0.00898	CbGeAlD
Verapamil—Petechiae—Epirubicin—thyroid cancer	0.000564	0.00595	CcSEcCtD
Verapamil—SLC6A4—head—thyroid cancer	0.000562	0.00892	CbGeAlD
Verapamil—ABCC4—head—thyroid cancer	0.00056	0.00888	CbGeAlD
Verapamil—Alopecia—Sorafenib—thyroid cancer	0.000557	0.00588	CcSEcCtD
Verapamil—ABCC1—thyroid gland—thyroid cancer	0.000538	0.00854	CbGeAlD
Verapamil—Muscle spasms—Sorafenib—thyroid cancer	0.000528	0.00557	CcSEcCtD
Verapamil—CACNA1C—lymph node—thyroid cancer	0.000522	0.00829	CbGeAlD
Verapamil—Petechiae—Doxorubicin—thyroid cancer	0.000522	0.0055	CcSEcCtD
Verapamil—Angioedema—Sorafenib—thyroid cancer	0.000501	0.00529	CcSEcCtD
Verapamil—Syncope—Sorafenib—thyroid cancer	0.000492	0.00519	CcSEcCtD
Verapamil—Loss of consciousness—Sorafenib—thyroid cancer	0.000482	0.00509	CcSEcCtD
Verapamil—Atrioventricular block—Epirubicin—thyroid cancer	0.000478	0.00505	CcSEcCtD
Verapamil—Asthenia—Vandetanib—thyroid cancer	0.000476	0.00503	CcSEcCtD
Verapamil—ABCC3—lymph node—thyroid cancer	0.000475	0.00754	CbGeAlD
Verapamil—Hypertension—Sorafenib—thyroid cancer	0.000474	0.005	CcSEcCtD
Verapamil—SLC22A5—thyroid gland—thyroid cancer	0.000473	0.00751	CbGeAlD
Verapamil—ABCC10—lymph node—thyroid cancer	0.000473	0.0075	CbGeAlD
Verapamil—Pruritus—Vandetanib—thyroid cancer	0.00047	0.00496	CcSEcCtD
Verapamil—Arthralgia—Sorafenib—thyroid cancer	0.000467	0.00493	CcSEcCtD
Verapamil—Myalgia—Sorafenib—thyroid cancer	0.000467	0.00493	CcSEcCtD
Verapamil—Dry mouth—Sorafenib—thyroid cancer	0.000457	0.00482	CcSEcCtD
Verapamil—Diarrhoea—Vandetanib—thyroid cancer	0.000454	0.00479	CcSEcCtD
Verapamil—Anaphylactic shock—Sorafenib—thyroid cancer	0.000448	0.00472	CcSEcCtD
Verapamil—ABCG2—thyroid gland—thyroid cancer	0.000446	0.00707	CbGeAlD
Verapamil—Infection—Sorafenib—thyroid cancer	0.000445	0.00469	CcSEcCtD
Verapamil—SLC22A4—lymph node—thyroid cancer	0.000444	0.00705	CbGeAlD
Verapamil—KCNH2—head—thyroid cancer	0.000444	0.00705	CbGeAlD
Verapamil—Atrioventricular block—Doxorubicin—thyroid cancer	0.000443	0.00467	CcSEcCtD
Verapamil—Shock—Sorafenib—thyroid cancer	0.000441	0.00465	CcSEcCtD
Verapamil—Dizziness—Vandetanib—thyroid cancer	0.000439	0.00463	CcSEcCtD
Verapamil—CYP1A2—thyroid gland—thyroid cancer	0.000429	0.0068	CbGeAlD
Verapamil—Vomiting—Vandetanib—thyroid cancer	0.000422	0.00445	CcSEcCtD
Verapamil—Rash maculo-papular—Epirubicin—thyroid cancer	0.000422	0.00445	CcSEcCtD
Verapamil—Ecchymosis—Epirubicin—thyroid cancer	0.000419	0.00442	CcSEcCtD
Verapamil—Rash—Vandetanib—thyroid cancer	0.000419	0.00442	CcSEcCtD
Verapamil—Dermatitis—Vandetanib—thyroid cancer	0.000418	0.00441	CcSEcCtD
Verapamil—Headache—Vandetanib—thyroid cancer	0.000416	0.00439	CcSEcCtD
Verapamil—Pulmonary oedema—Epirubicin—thyroid cancer	0.000413	0.00436	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000408	0.0043	CcSEcCtD
Verapamil—Dyspnoea—Sorafenib—thyroid cancer	0.000399	0.00421	CcSEcCtD
Verapamil—Nausea—Vandetanib—thyroid cancer	0.000394	0.00416	CcSEcCtD
Verapamil—Dyspepsia—Sorafenib—thyroid cancer	0.000394	0.00416	CcSEcCtD
Verapamil—ABCC4—lymph node—thyroid cancer	0.000392	0.00622	CbGeAlD
Verapamil—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00039	0.00412	CcSEcCtD
Verapamil—Ecchymosis—Doxorubicin—thyroid cancer	0.000388	0.00409	CcSEcCtD
Verapamil—Fatigue—Sorafenib—thyroid cancer	0.000386	0.00407	CcSEcCtD
Verapamil—Constipation—Sorafenib—thyroid cancer	0.000383	0.00404	CcSEcCtD
Verapamil—Pain—Sorafenib—thyroid cancer	0.000383	0.00404	CcSEcCtD
Verapamil—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000382	0.00403	CcSEcCtD
Verapamil—ABCC2—lymph node—thyroid cancer	0.00038	0.00602	CbGeAlD
Verapamil—Vascular purpura—Epirubicin—thyroid cancer	0.000376	0.00397	CcSEcCtD
Verapamil—CYP2B6—head—thyroid cancer	0.000365	0.00579	CbGeAlD
Verapamil—Urticaria—Sorafenib—thyroid cancer	0.000356	0.00375	CcSEcCtD
Verapamil—Purpura—Epirubicin—thyroid cancer	0.000349	0.00369	CcSEcCtD
Verapamil—Vascular purpura—Doxorubicin—thyroid cancer	0.000348	0.00367	CcSEcCtD
Verapamil—Cardiac failure—Epirubicin—thyroid cancer	0.000345	0.00364	CcSEcCtD
Verapamil—Lethargy—Epirubicin—thyroid cancer	0.000344	0.00363	CcSEcCtD
Verapamil—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000344	0.00363	CcSEcCtD
Verapamil—Diplopia—Epirubicin—thyroid cancer	0.000337	0.00355	CcSEcCtD
Verapamil—ABCC1—lymph node—thyroid cancer	0.000334	0.0053	CbGeAlD
Verapamil—Hypersensitivity—Sorafenib—thyroid cancer	0.00033	0.00348	CcSEcCtD
Verapamil—Purpura—Doxorubicin—thyroid cancer	0.000323	0.00341	CcSEcCtD
Verapamil—Asthenia—Sorafenib—thyroid cancer	0.000321	0.00339	CcSEcCtD
Verapamil—Cardiac arrest—Epirubicin—thyroid cancer	0.00032	0.00338	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—thyroid cancer	0.000319	0.00337	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—thyroid cancer	0.000318	0.00335	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000318	0.00335	CcSEcCtD
Verapamil—Pruritus—Sorafenib—thyroid cancer	0.000317	0.00334	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—thyroid cancer	0.000312	0.00329	CcSEcCtD
Verapamil—KCNH2—lymph node—thyroid cancer	0.000311	0.00494	CbGeAlD
Verapamil—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000308	0.00324	CcSEcCtD
Verapamil—Diarrhoea—Sorafenib—thyroid cancer	0.000306	0.00323	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—thyroid cancer	0.000297	0.00313	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—thyroid cancer	0.000296	0.00313	CcSEcCtD
Verapamil—Dizziness—Sorafenib—thyroid cancer	0.000296	0.00312	CcSEcCtD
Verapamil—SLC22A5—lymph node—thyroid cancer	0.000294	0.00467	CbGeAlD
Verapamil—Influenza—Epirubicin—thyroid cancer	0.000291	0.00307	CcSEcCtD
Verapamil—Vomiting—Sorafenib—thyroid cancer	0.000285	0.003	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000285	0.003	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—thyroid cancer	0.000284	0.00299	CcSEcCtD
Verapamil—Rash—Sorafenib—thyroid cancer	0.000282	0.00298	CcSEcCtD
Verapamil—Dermatitis—Sorafenib—thyroid cancer	0.000282	0.00298	CcSEcCtD
Verapamil—Headache—Sorafenib—thyroid cancer	0.000281	0.00296	CcSEcCtD
Verapamil—ABCB1—trachea—thyroid cancer	0.000278	0.00441	CbGeAlD
Verapamil—ABCG2—lymph node—thyroid cancer	0.000277	0.00439	CbGeAlD
Verapamil—Muscular weakness—Doxorubicin—thyroid cancer	0.000275	0.0029	CcSEcCtD
Verapamil—CYP2D6—head—thyroid cancer	0.000271	0.0043	CbGeAlD
Verapamil—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000271	0.00285	CcSEcCtD
Verapamil—Influenza—Doxorubicin—thyroid cancer	0.000269	0.00284	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—thyroid cancer	0.000269	0.00284	CcSEcCtD
Verapamil—Nausea—Sorafenib—thyroid cancer	0.000266	0.00281	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—thyroid cancer	0.000262	0.00277	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—thyroid cancer	0.00026	0.00274	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000257	0.00271	CcSEcCtD
Verapamil—Jaundice—Epirubicin—thyroid cancer	0.000253	0.00267	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00025	0.00264	CcSEcCtD
Verapamil—Sweating—Epirubicin—thyroid cancer	0.000249	0.00262	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—thyroid cancer	0.000249	0.00262	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—thyroid cancer	0.000244	0.00257	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—thyroid cancer	0.00024	0.00253	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000238	0.00251	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—thyroid cancer	0.000237	0.0025	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—thyroid cancer	0.000234	0.00247	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—thyroid cancer	0.000234	0.00246	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—thyroid cancer	0.000233	0.00246	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—thyroid cancer	0.000232	0.00245	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—thyroid cancer	0.000231	0.00244	CcSEcCtD
Verapamil—Sweating—Doxorubicin—thyroid cancer	0.00023	0.00243	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—thyroid cancer	0.00023	0.00242	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—thyroid cancer	0.000225	0.00238	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—thyroid cancer	0.000225	0.00237	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—thyroid cancer	0.00022	0.00232	CcSEcCtD
Verapamil—ABCB1—thyroid gland—thyroid cancer	0.00022	0.00349	CbGeAlD
Verapamil—Bradycardia—Doxorubicin—thyroid cancer	0.000219	0.00232	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—thyroid cancer	0.000217	0.00229	CcSEcCtD
Verapamil—Flushing—Epirubicin—thyroid cancer	0.000216	0.00228	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—thyroid cancer	0.000216	0.00228	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—thyroid cancer	0.000216	0.00227	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000215	0.00226	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—thyroid cancer	0.000214	0.00226	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—thyroid cancer	0.000212	0.00224	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—thyroid cancer	0.000208	0.00219	CcSEcCtD
Verapamil—Alopecia—Epirubicin—thyroid cancer	0.000206	0.00217	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—thyroid cancer	0.000204	0.00215	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—thyroid cancer	0.000201	0.00212	CcSEcCtD
Verapamil—Flushing—Doxorubicin—thyroid cancer	0.0002	0.00211	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—thyroid cancer	0.000195	0.00206	CcSEcCtD
Verapamil—ABCB1—head—thyroid cancer	0.000195	0.00309	CbGeAlD
Verapamil—Vision blurred—Epirubicin—thyroid cancer	0.000191	0.00202	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—thyroid cancer	0.000191	0.00201	CcSEcCtD
Verapamil—Agitation—Epirubicin—thyroid cancer	0.000186	0.00197	CcSEcCtD
Verapamil—Vertigo—Epirubicin—thyroid cancer	0.000182	0.00192	CcSEcCtD
Verapamil—Syncope—Epirubicin—thyroid cancer	0.000182	0.00192	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—thyroid cancer	0.00018	0.0019	CcSEcCtD
Verapamil—Palpitations—Epirubicin—thyroid cancer	0.000179	0.00189	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—thyroid cancer	0.000178	0.00188	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—thyroid cancer	0.000177	0.00187	CcSEcCtD
Verapamil—Convulsion—Epirubicin—thyroid cancer	0.000176	0.00185	CcSEcCtD
Verapamil—Hypertension—Epirubicin—thyroid cancer	0.000175	0.00185	CcSEcCtD
Verapamil—Myalgia—Epirubicin—thyroid cancer	0.000173	0.00182	CcSEcCtD
Verapamil—Chest pain—Epirubicin—thyroid cancer	0.000173	0.00182	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—thyroid cancer	0.000173	0.00182	CcSEcCtD
Verapamil—Agitation—Doxorubicin—thyroid cancer	0.000172	0.00182	CcSEcCtD
Verapamil—Discomfort—Epirubicin—thyroid cancer	0.000171	0.0018	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—thyroid cancer	0.000169	0.00178	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—thyroid cancer	0.000169	0.00178	CcSEcCtD
Verapamil—Syncope—Doxorubicin—thyroid cancer	0.000168	0.00178	CcSEcCtD
Verapamil—Confusional state—Epirubicin—thyroid cancer	0.000167	0.00176	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—thyroid cancer	0.000166	0.00175	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—thyroid cancer	0.000166	0.00175	CcSEcCtD
Verapamil—Oedema—Epirubicin—thyroid cancer	0.000166	0.00175	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—thyroid cancer	0.000165	0.00174	CcSEcCtD
Verapamil—Infection—Epirubicin—thyroid cancer	0.000164	0.00173	CcSEcCtD
Verapamil—Shock—Epirubicin—thyroid cancer	0.000163	0.00172	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—thyroid cancer	0.000163	0.00172	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—thyroid cancer	0.000162	0.00171	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—thyroid cancer	0.000162	0.0017	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—thyroid cancer	0.00016	0.00169	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—thyroid cancer	0.00016	0.00169	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—thyroid cancer	0.00016	0.00169	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—thyroid cancer	0.00016	0.00169	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—thyroid cancer	0.000158	0.00167	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—thyroid cancer	0.000156	0.00165	CcSEcCtD
Verapamil—Hypotension—Epirubicin—thyroid cancer	0.000155	0.00163	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—thyroid cancer	0.000154	0.00163	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000153	0.00162	CcSEcCtD
Verapamil—Oedema—Doxorubicin—thyroid cancer	0.000153	0.00162	CcSEcCtD
Verapamil—Infection—Doxorubicin—thyroid cancer	0.000152	0.00161	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000151	0.00159	CcSEcCtD
Verapamil—Shock—Doxorubicin—thyroid cancer	0.000151	0.00159	CcSEcCtD
Verapamil—Insomnia—Epirubicin—thyroid cancer	0.00015	0.00158	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—thyroid cancer	0.000149	0.00158	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—thyroid cancer	0.000149	0.00157	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000148	0.00156	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—thyroid cancer	0.000148	0.00156	CcSEcCtD
Verapamil—Somnolence—Epirubicin—thyroid cancer	0.000147	0.00155	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—thyroid cancer	0.000146	0.00154	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—thyroid cancer	0.000143	0.00151	CcSEcCtD
Verapamil—Fatigue—Epirubicin—thyroid cancer	0.000143	0.00151	CcSEcCtD
Verapamil—Constipation—Epirubicin—thyroid cancer	0.000142	0.00149	CcSEcCtD
Verapamil—Pain—Epirubicin—thyroid cancer	0.000142	0.00149	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00014	0.00147	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—thyroid cancer	0.000139	0.00146	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—thyroid cancer	0.000138	0.00145	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—thyroid cancer	0.000137	0.00144	CcSEcCtD
Verapamil—ABCB1—lymph node—thyroid cancer	0.000136	0.00217	CbGeAlD
Verapamil—Feeling abnormal—Epirubicin—thyroid cancer	0.000136	0.00144	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—thyroid cancer	0.000136	0.00144	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—thyroid cancer	0.000135	0.00142	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—thyroid cancer	0.000132	0.00139	CcSEcCtD
Verapamil—Urticaria—Epirubicin—thyroid cancer	0.000132	0.00139	CcSEcCtD
Verapamil—Pain—Doxorubicin—thyroid cancer	0.000131	0.00138	CcSEcCtD
Verapamil—Constipation—Doxorubicin—thyroid cancer	0.000131	0.00138	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—thyroid cancer	0.000126	0.00133	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—thyroid cancer	0.000122	0.00129	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—thyroid cancer	0.000122	0.00128	CcSEcCtD
Verapamil—Asthenia—Epirubicin—thyroid cancer	0.000119	0.00125	CcSEcCtD
Verapamil—Pruritus—Epirubicin—thyroid cancer	0.000117	0.00124	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—thyroid cancer	0.000113	0.00119	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—thyroid cancer	0.000113	0.00119	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—thyroid cancer	0.00011	0.00116	CcSEcCtD
Verapamil—Dizziness—Epirubicin—thyroid cancer	0.000109	0.00115	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—thyroid cancer	0.000108	0.00114	CcSEcCtD
Verapamil—Vomiting—Epirubicin—thyroid cancer	0.000105	0.00111	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—thyroid cancer	0.000105	0.00111	CcSEcCtD
Verapamil—Rash—Epirubicin—thyroid cancer	0.000104	0.0011	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—thyroid cancer	0.000104	0.0011	CcSEcCtD
Verapamil—Headache—Epirubicin—thyroid cancer	0.000104	0.00109	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—thyroid cancer	0.000101	0.00107	CcSEcCtD
Verapamil—Nausea—Epirubicin—thyroid cancer	9.83e-05	0.00104	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—thyroid cancer	9.74e-05	0.00103	CcSEcCtD
Verapamil—Rash—Doxorubicin—thyroid cancer	9.66e-05	0.00102	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—thyroid cancer	9.65e-05	0.00102	CcSEcCtD
Verapamil—Headache—Doxorubicin—thyroid cancer	9.6e-05	0.00101	CcSEcCtD
Verapamil—Nausea—Doxorubicin—thyroid cancer	9.1e-05	0.00096	CcSEcCtD
Verapamil—CACNA1D—Developmental Biology—NRAS—thyroid cancer	2.76e-05	0.000265	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—HRAS—thyroid cancer	2.74e-05	0.000263	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PRKAR1A—thyroid cancer	2.74e-05	0.000263	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—SLC5A5—thyroid cancer	2.73e-05	0.000262	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CHST14—thyroid cancer	2.7e-05	0.000259	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CHST14—thyroid cancer	2.67e-05	0.000257	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—AKT1—thyroid cancer	2.67e-05	0.000256	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—SLC5A5—thyroid cancer	2.66e-05	0.000255	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HPGD—thyroid cancer	2.65e-05	0.000254	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—TPR—thyroid cancer	2.65e-05	0.000254	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.62e-05	0.000251	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	2.6e-05	0.00025	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.6e-05	0.00025	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PTGS2—thyroid cancer	2.59e-05	0.000249	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—AKT1—thyroid cancer	2.59e-05	0.000248	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—HRAS—thyroid cancer	2.51e-05	0.000241	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.51e-05	0.000241	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—KRAS—thyroid cancer	2.51e-05	0.000241	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—RXRA—thyroid cancer	2.49e-05	0.000239	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.49e-05	0.000239	CbGpPWpGaD
Verapamil—ABCC1—Disease—CALCA—thyroid cancer	2.49e-05	0.000239	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—HRAS—thyroid cancer	2.49e-05	0.000239	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—HRAS—thyroid cancer	2.48e-05	0.000238	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.48e-05	0.000238	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—TPR—thyroid cancer	2.45e-05	0.000235	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NRAS—thyroid cancer	2.45e-05	0.000235	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTGS2—thyroid cancer	2.44e-05	0.000234	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.43e-05	0.000233	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—TPR—thyroid cancer	2.43e-05	0.000233	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NRAS—thyroid cancer	2.42e-05	0.000233	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PRKAR1A—thyroid cancer	2.41e-05	0.000231	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.39e-05	0.000229	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—KRAS—thyroid cancer	2.37e-05	0.000228	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HPGD—thyroid cancer	2.36e-05	0.000227	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.36e-05	0.000226	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—RXRA—thyroid cancer	2.33e-05	0.000224	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	2.32e-05	0.000222	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HPGD—thyroid cancer	2.31e-05	0.000221	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—RXRA—thyroid cancer	2.3e-05	0.000221	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CHST14—thyroid cancer	2.28e-05	0.000219	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.27e-05	0.000218	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PTEN—thyroid cancer	2.26e-05	0.000217	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—TPR—thyroid cancer	2.26e-05	0.000217	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDK1—thyroid cancer	2.25e-05	0.000216	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—RXRA—thyroid cancer	2.23e-05	0.000215	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.23e-05	0.000214	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	2.22e-05	0.000213	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.2e-05	0.000212	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—AKT1—thyroid cancer	2.19e-05	0.000211	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.17e-05	0.000209	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HPGD—thyroid cancer	2.17e-05	0.000209	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.17e-05	0.000208	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HPGD—thyroid cancer	2.15e-05	0.000207	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.15e-05	0.000206	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—HRAS—thyroid cancer	2.13e-05	0.000205	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTEN—thyroid cancer	2.13e-05	0.000204	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.12e-05	0.000203	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—KRAS—thyroid cancer	2.11e-05	0.000202	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—KRAS—thyroid cancer	2.09e-05	0.0002	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.08e-05	0.0002	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.08e-05	0.0002	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—HRAS—thyroid cancer	2.02e-05	0.000194	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.01e-05	0.000193	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NRAS—thyroid cancer	2e-05	0.000192	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	1.98e-05	0.00019	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.95e-05	0.000187	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—RXRA—thyroid cancer	1.95e-05	0.000187	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.94e-05	0.000186	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.92e-05	0.000184	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.89e-05	0.000182	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PPARG—thyroid cancer	1.89e-05	0.000182	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—AKT1—thyroid cancer	1.88e-05	0.000181	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.87e-05	0.00018	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.86e-05	0.000178	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HPGD—thyroid cancer	1.84e-05	0.000177	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.83e-05	0.000176	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.82e-05	0.000175	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRG1—thyroid cancer	1.81e-05	0.000174	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PPARG—thyroid cancer	1.81e-05	0.000173	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TPR—thyroid cancer	1.8e-05	0.000172	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PPARG—thyroid cancer	1.79e-05	0.000172	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—thyroid cancer	1.79e-05	0.000172	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—AKT1—thyroid cancer	1.78e-05	0.000171	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.78e-05	0.000171	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—thyroid cancer	1.77e-05	0.00017	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.77e-05	0.00017	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CHST14—thyroid cancer	1.76e-05	0.000169	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TPR—thyroid cancer	1.76e-05	0.000169	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—RXRA—thyroid cancer	1.75e-05	0.000168	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.75e-05	0.000168	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.73e-05	0.000166	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—KRAS—thyroid cancer	1.72e-05	0.000165	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.7e-05	0.000164	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—SLC5A5—thyroid cancer	1.69e-05	0.000162	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—RXRA—thyroid cancer	1.66e-05	0.00016	CbGpPWpGaD
Verapamil—ABCC1—Disease—TERT—thyroid cancer	1.62e-05	0.000156	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.62e-05	0.000155	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—thyroid cancer	1.6e-05	0.000153	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—AKT1—thyroid cancer	1.58e-05	0.000152	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PPARG—thyroid cancer	1.57e-05	0.000151	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—AKT1—thyroid cancer	1.57e-05	0.00015	CbGpPWpGaD
Verapamil—ABCC1—Disease—HIF1A—thyroid cancer	1.55e-05	0.000149	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—RXRA—thyroid cancer	1.54e-05	0.000148	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—thyroid cancer	1.53e-05	0.000147	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—RXRA—thyroid cancer	1.53e-05	0.000147	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TPR—thyroid cancer	1.52e-05	0.000146	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.5e-05	0.000144	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.49e-05	0.000143	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.49e-05	0.000143	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—thyroid cancer	1.49e-05	0.000143	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000141	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—thyroid cancer	1.47e-05	0.000141	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PPARG—thyroid cancer	1.45e-05	0.000139	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—RXRA—thyroid cancer	1.42e-05	0.000136	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HPGD—thyroid cancer	1.42e-05	0.000136	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—thyroid cancer	1.42e-05	0.000136	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PPARG—thyroid cancer	1.41e-05	0.000135	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—thyroid cancer	1.41e-05	0.000135	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TPR—thyroid cancer	1.36e-05	0.00013	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.36e-05	0.00013	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.34e-05	0.000129	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.34e-05	0.000128	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TPR—thyroid cancer	1.32e-05	0.000127	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.32e-05	0.000127	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.31e-05	0.000126	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.3e-05	0.000125	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AKT1—thyroid cancer	1.3e-05	0.000125	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTEN—thyroid cancer	1.3e-05	0.000125	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—AKT1—thyroid cancer	1.29e-05	0.000124	CbGpPWpGaD
Verapamil—ABCC1—Disease—BRAF—thyroid cancer	1.29e-05	0.000123	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TPR—thyroid cancer	1.25e-05	0.00012	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—thyroid cancer	1.24e-05	0.000119	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTEN—thyroid cancer	1.24e-05	0.000119	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TPR—thyroid cancer	1.24e-05	0.000119	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTEN—thyroid cancer	1.23e-05	0.000118	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.23e-05	0.000118	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	0.000118	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AKT1—thyroid cancer	1.22e-05	0.000118	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.22e-05	0.000117	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.21e-05	0.000116	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.000111	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.14e-05	0.00011	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.14e-05	0.000109	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—RXRA—thyroid cancer	1.13e-05	0.000108	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.12e-05	0.000107	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—thyroid cancer	1.11e-05	0.000107	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PPARG—thyroid cancer	1.11e-05	0.000106	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—RXRA—thyroid cancer	1.1e-05	0.000106	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.1e-05	0.000106	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTEN—thyroid cancer	1.08e-05	0.000104	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.07e-05	0.000102	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TPR—thyroid cancer	1.06e-05	0.000102	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.05e-05	0.000101	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.04e-05	9.99e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—thyroid cancer	1.04e-05	9.97e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.02e-05	9.75e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTEN—thyroid cancer	1.01e-05	9.69e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTEN—thyroid cancer	9.95e-06	9.55e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SLC5A5—thyroid cancer	9.92e-06	9.52e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—thyroid cancer	9.73e-06	9.34e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTEN—thyroid cancer	9.68e-06	9.29e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—thyroid cancer	9.67e-06	9.28e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—thyroid cancer	9.64e-06	9.26e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—RXRA—thyroid cancer	9.56e-06	9.18e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.52e-06	9.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.43e-06	9.05e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SLC5A5—thyroid cancer	9.34e-06	8.97e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.3e-06	8.93e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SLC5A5—thyroid cancer	9.26e-06	8.89e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTEN—thyroid cancer	9.06e-06	8.69e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—thyroid cancer	8.97e-06	8.61e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—thyroid cancer	8.7e-06	8.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.68e-06	8.33e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—RXRA—thyroid cancer	8.54e-06	8.19e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTEN—thyroid cancer	8.43e-06	8.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—RXRA—thyroid cancer	8.33e-06	8e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.3e-06	7.97e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—thyroid cancer	8.27e-06	7.93e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TPR—thyroid cancer	8.16e-06	7.83e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—thyroid cancer	8.08e-06	7.76e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.03e-06	7.71e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC5A5—thyroid cancer	7.92e-06	7.6e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—RXRA—thyroid cancer	7.85e-06	7.54e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—RXRA—thyroid cancer	7.78e-06	7.47e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—thyroid cancer	7.65e-06	7.35e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—thyroid cancer	7.59e-06	7.28e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTEN—thyroid cancer	7.59e-06	7.28e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.57e-06	7.27e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—thyroid cancer	7.48e-06	7.18e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.42e-06	7.12e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTEN—thyroid cancer	7.21e-06	6.92e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—thyroid cancer	7.14e-06	6.85e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—thyroid cancer	7.13e-06	6.85e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—thyroid cancer	7.09e-06	6.8e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—thyroid cancer	7.06e-06	6.78e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—thyroid cancer	6.97e-06	6.69e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—thyroid cancer	6.95e-06	6.68e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTEN—thyroid cancer	6.67e-06	6.41e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—RXRA—thyroid cancer	6.65e-06	6.38e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTEN—thyroid cancer	6.62e-06	6.35e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.47e-06	6.21e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—thyroid cancer	6.23e-06	5.98e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTEN—thyroid cancer	6.16e-06	5.91e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.11e-06	5.86e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—thyroid cancer	6.04e-06	5.8e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—thyroid cancer	5.91e-06	5.67e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—thyroid cancer	5.82e-06	5.59e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—thyroid cancer	5.74e-06	5.51e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—thyroid cancer	5.61e-06	5.39e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—thyroid cancer	5.58e-06	5.36e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—thyroid cancer	5.48e-06	5.26e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—thyroid cancer	5.39e-06	5.17e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—thyroid cancer	5.26e-06	5.05e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—thyroid cancer	5.22e-06	5.01e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—RXRA—thyroid cancer	5.13e-06	4.93e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—thyroid cancer	4.96e-06	4.76e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—thyroid cancer	4.91e-06	4.72e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTEN—thyroid cancer	4.89e-06	4.7e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—thyroid cancer	4.86e-06	4.66e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTEN—thyroid cancer	4.78e-06	4.59e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.75e-06	4.56e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—thyroid cancer	4.37e-06	4.2e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.24e-06	4.07e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—thyroid cancer	4.2e-06	4.03e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—thyroid cancer	4.15e-06	3.99e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTEN—thyroid cancer	4.14e-06	3.98e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—thyroid cancer	4.14e-06	3.97e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.9e-06	3.74e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.87e-06	3.71e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—thyroid cancer	3.85e-06	3.69e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—thyroid cancer	3.81e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTEN—thyroid cancer	3.7e-06	3.55e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTEN—thyroid cancer	3.61e-06	3.46e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—thyroid cancer	3.55e-06	3.41e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTEN—thyroid cancer	3.4e-06	3.26e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTEN—thyroid cancer	3.37e-06	3.24e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.3e-06	3.17e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—thyroid cancer	3.24e-06	3.11e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTEN—thyroid cancer	2.88e-06	2.77e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—thyroid cancer	2.82e-06	2.71e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—thyroid cancer	2.76e-06	2.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.55e-06	2.45e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—thyroid cancer	2.39e-06	2.29e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTEN—thyroid cancer	2.22e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—thyroid cancer	2.13e-06	2.05e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—thyroid cancer	2.08e-06	2e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—thyroid cancer	1.96e-06	1.88e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—thyroid cancer	1.94e-06	1.87e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—thyroid cancer	1.66e-06	1.59e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—thyroid cancer	1.28e-06	1.23e-05	CbGpPWpGaD
